BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11816717)

  • 1. Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia--possible role of platelet activation.
    Mellembakken JR; Solum NO; Ueland T; Videm V; Aukrust P
    Thromb Haemost; 2001 Nov; 86(5):1272-6. PubMed ID: 11816717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased concentration of soluble CD40 ligand in preeclampsia.
    Alacacioglu I; Ozcan MA; Piskin O; Yuksel F; Alacacioglu A; Demirkan F; Ozsan HG; Polat M; Ozgenc Y; Undar B
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):201-5. PubMed ID: 17456631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells.
    Damås JK; Otterdal K; Yndestad A; Aass H; Solum NO; Frøland SS; Simonsen S; Aukrust P; Andreassen AK
    Circulation; 2004 Aug; 110(8):999-1005. PubMed ID: 15302794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and concentration of CD40 ligand in normal pregnancy, preeclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome.
    Azzam HA; Abousamra NK; Goda H; El-Shouky R; El-Gilany AH
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):71-5. PubMed ID: 23241952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric investigation of CD40-CD40 ligand system in preeclampsia and normal pregnancy.
    Lukanov TH; Bojinova SI; Popova VS; Emin AL; Veleva GL; Gecheva SP; Konova EI
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):306-12. PubMed ID: 19221099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of platelet-derived chemokines (RANTES and ENA-78) after stem cell transplantation.
    Nomura S; Ishii K; Kanazawa S; Inami N; Kamitsuji Y; Uoshima N; Ishida H; Yoshihara T; Kitayama H; Hayashi K
    Transpl Immunol; 2006 Apr; 15(4):247-53. PubMed ID: 16635746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.
    Furuse S; Fujii H; Kaburagi Y; Fujimoto M; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2003 Jul; 30(7):1524-8. PubMed ID: 12858452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
    Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
    Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia.
    Oron G; Ben-Haroush A; Hod M; Orvieto R; Bar J
    Obstet Gynecol; 2006 Apr; 107(4):896-900. PubMed ID: 16582129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.
    Lee SP; Ataga KI; Orringer EP; Phillips DR; Parise LV
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1626-31. PubMed ID: 16601237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of soluble CD40 ligand after platelet activation: studies on the solubilization phase.
    Otterdal K; Pedersen TM; Solum NO
    Thromb Res; 2004; 114(3):167-77. PubMed ID: 15342213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF.
    Nomura S; Inami N; Kanazawa S; Iwasaka T; Fukuhara S
    Stem Cells; 2004; 22(5):696-703. PubMed ID: 15342934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.
    Menchén L; Marín-Jiménez I; Arias-Salgado EG; Fontela T; Hernández-Sampelayo P; Rodríguez MC; Butta NV
    Gut; 2009 Jul; 58(7):920-8. PubMed ID: 19039088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of soluble CD40 ligand released from human activated platelets.
    Jin Y; Nonoyama S; Morio T; Imai K; Ochs HD; Mizutani S
    J Med Dent Sci; 2001 Mar; 48(1):23-7. PubMed ID: 12160239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
    Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
    Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and expression of Gro-alpha and RANTES by peripheral blood mononuclear cells isolated from patients with Kawasaki disease and measles.
    Kim HS; Kim WD; Lee YH
    J Korean Med Sci; 2003 Jun; 18(3):381-6. PubMed ID: 12808325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines and leukocyte activation in the fetal circulation during preeclampsia.
    Mellembakken JR; Aukrust P; Hestdal K; Ueland T; Abyholm T; Videm V
    Hypertension; 2001 Sep; 38(3):394-8. PubMed ID: 11566911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil CD40 enhances platelet-mediated inflammation.
    Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
    Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium.
    Rudack C; Steinhoff M; Mooren F; Buddenkotte J; Becker K; von Eiff C; Sachse F
    Clin Exp Allergy; 2007 Jul; 37(7):1009-22. PubMed ID: 17581194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
    Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
    Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.